Dragonfly Therapeutics Inc. added Gilead Sciences Inc. to its roster of partnerships in a deal that gives the Waltham, Mass.-based company $300 million up front, with opt-in payments, milestones and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback